Evidence map›Paper›PMID 40684174›Full record

ArticleMolecular cancer2025

CircABCA1 promotes ccRCC by reprogramming cholesterol metabolism and facilitating M2 macrophage polarization through IGF2BP3-mediated stabilization of SCARB1 mRNA.

Hao Ning, Yan Jiang, Binbin Li, Junwu Ren, Cong Wang, Ling Wei, Linfei Li, Ai Ran, Zuozhang Li, Jiao Li and 3 more

Abstract read
In one paragraph

Article in Molecular cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Insights Into circRNA-Mediated Lipid Metabolism in Cancer Progression.Journal of cellular and molecular medicine · 2026
    Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. A novel prognostic and immune-related biomarkerTranslational cancer research · 2025
    Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Hao Ning *Department of Gastrointestinal Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People's Republic of China.
Yan Jiang *College of Pharmacy, Chongqing Medical University, Chongqing, 400016, People's Republic of China.
Binbin LiCollege of Pharmacy, Chongqing Medical University, Chongqing, 400016, People's Republic of China.
Junwu RenCollege of Pharmacy, Chongqing Medical University, Chongqing, 400016, People's Republic of China.
Cong WangDepartment of Urology, Southwest Hospital, Army Medical University, Chongqing, 400030, People's Republic of China.
Ling WeiDepartment of Urology, Southwest Hospital, Army Medical University, Chongqing, 400030, People's Republic of China.
Linfei LiDepartment of Urology, Southwest Hospital, Army Medical University, Chongqing, 400030, People's Republic of China.
Ai RanCollege of Pharmacy, Chongqing Medical University, Chongqing, 400016, People's Republic of China.
Zuozhang LiCollege of Pharmacy, Chongqing Medical University, Chongqing, 400016, People's Republic of China.
Jiao LiCollege of Pharmacy, Chongqing Medical University, Chongqing, 400016, People's Republic of China.
Wei LiDepartment of Pharmacy, Chongqing University Cancer Hospital, Chongqing, 400030, People's Republic of China. liwei.tmmu@163.com.
Yongquan WangDepartment of Urology, Southwest Hospital, Army Medical University, Chongqing, 400030, People's Republic of China. wangyongquan@aliyun.com.
Bin XiaoCollege of Pharmacy, Chongqing Medical University, Chongqing, 400016, People's Republic of China. binxiaocqmu@cqmu.edu.cn.

Funding

Chongqing Natural Science Foundation Innovation and Development Joint Fund CSTB2022NSCQ-LZX0043Chongqing Talents-Exceptional Young Talents Project CQYC202005044Future Medical Youth Innovation Team Project of Chongqing Medical University W0042Graduate Tutor Team Construction Project of Chongqing CQMUDSTD202210National Natural Science Foundation of China 82373001Natural Science Foundation of Chongqing CSTC2022JXJL120012Science and Technology Research Project of Chongqing Municipal Education Commission KJZD-K202100405Top Graduate Talent Cultivation Program of Chongqing Medical University BJRC202322
6 · The paper itself

Abstract

backgroundThe reliance of clear cell renal cell carcinoma (ccRCC) on exogenous cholesterol import implies a metabolic susceptibility. This susceptibility represents a potential avenue that can be exploited as a novel therapeutic approach for ccRCC. Circular RNAs (circRNAs) are emerging regulators in cancer, yet their roles in ccRCC lipid metabolism and tumor microenvironment remodeling remain unclear. This study investigates the tumor-promoting role of circABCA1 in ccRCC cholesterol homeostasis and M2 macrophage polarization.

methodsThe expression levels of circABCA1, IGF2BP3, SCARB1, autophagy-related proteins, and the IGF1R/PI3K/AKT/mTOR and ABCA1/ABCG1 pathways were measured using RT-qPCR and western blot. Untargeted metabolomics, RNA- sequencing, and MS2 RNA-pulldown were conducted to identify targets. Interaction analyses included RNA immunoprecipitation, RNA pull-down, and RNA fluorescence in situ hybridization (FISH) assays. Lipid raft measurements, cholesterol uptake/efflux assays, and lipophagy assessments were performed. A co-culture system between M2 macrophages and ccRCC cells was established. In vivo tumorigenesis and metastasis were evaluated using xenograft models and a hepatic metastasis model. Statistical analyses involved Student's t-tests and ANOVA; significance set at P < 0.05.

resultsWe identified a novel lipid metabolism-related circRNA, circABCA1, which was upregulated in ccRCC and positively correlated with tumor stage and distant metastasis. Functionally, circABCA1 enhanced the half-life of SCARB1 mRNA by forming a circABCA1-IGF2BP3-SCARB1 mRNA ternary complex, thereby increasing the expression of SCARB1 and consequent cholesterol uptake. Next, elevated cholesterol caused by circABCA1-SCARB1 axis-maintained lipid rafts, initiated IGF1R/PI3K/AKT/mTOR cascade, and protected lipid droplets from being destructed by lipophagy, leading to decreased cholesterol efflux. CircABCA1 facilitated the proliferation and migration of ccRCC in vitro and in vivo in a SCARB1 depended manner. Moreover, we uncovered that circABCA1 facilitated M2 macrophage polarization and subsequent pro-tumor effect by prompting cholesterol uptake of ccRCC from tumor microenvironment in a SCARB1-dependent manner.

conclusionsCircABCA1 plays a crucial role in promoting ccRCC progression by regulating cholesterol metabolism and facilitating M2 macrophage polarization, representing a potential therapeutic target for ccRCC treatment.

Indexed as

Carcinoma, Renal CellCholesterolKidney NeoplasmsMacrophagesRNA-Binding ProteinsRNA, CircularRNA, MessengerScavenger Receptors, Class BAnimalsCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticHumansLipid MetabolismMaleMiceCholesterolRNA-Binding ProteinsRNA, CircularRNA, MessengerSCARB1 protein, humanScavenger Receptors, Class BCcRCCCholesterolCircABCA1MacrophagesTernary complex

Identifiers

PMID40684174
PMCPMC12275331

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.